IPAS members discover biomarkers in blood which could detect stomach cancer
A simple blood test could be used to discover stomach cancer, giving new hope to early detection of the disease and reducing the need for invasive endoscopies.
Associate Professor Peter Hoffmann, project leader and Director of the University’s Adelaide Proteomics Centre, said the researchers had identified four new proteins that change in concentration in the blood of stomach cancer patients.
“Using the four markers together produces high levels of selectivity and sensitivity in detecting stomach cancer,” he said.
The biomarkers are subject to a Provisional Cooperation Treaty patent and commercial partners are being sought. Clinical trials in large patient numbers would then need to be conducted, and if successful would mean a widely available test could be three to five years away.
Associate Professor Hoffman said that blood test, which would cost between $30-$50 each, could lead to a widescale screening program for people over a certain age.
Stomach or gastric cancer is the fourth most common cancer in the world and the second leading cause of death due to cancer.